Hepatitis C virus: Morphogenesis, infection and therapy

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis C virus (HCV) is a significant global health concern, causing liver cirrhosis and cancer.
• HCV infection impacts approximately 3% of the world's population, with high endemic rates in certain countries.
• Understanding HCV is crucial for public health due to its widespread prevalence and severe liver-related outcomes.

Purpose of the Study:

• To review recent advancements in Hepatitis C virus (HCV) molecular biology.
• To summarize the physiopathology of HCV infection, including immune-mediated damage, fibrosis, and lipid metabolism.
• To describe current diagnostic and therapeutic strategies for HCV, alongside available research models.

Main Methods:

• Literature review of recent data on HCV.
• Analysis of studies on HCV molecular biology and pathogenesis.
• Compilation of information on diagnostic tools, treatments, and experimental models.

Main Results:

• HCV infection leads to significant liver damage, including fibrosis and cancer.
• Current research encompasses viral molecular mechanisms, host immune responses, and metabolic alterations.
• Various in vitro, ex vivo, and animal models are available for studying HCV.

Conclusions:

• A comprehensive understanding of host and viral factors is essential for advancing HCV research.
• Continued investigation into HCV pathogenesis and host interactions may pave the way for novel therapeutic vaccines.
• Further research into HCV is critical for developing effective prevention and treatment strategies.